Keyphrases
Molecular Approaches
100%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
100%
Philadelphia
100%
Philadelphia-like
100%
Minimal Residual Disease
38%
Quantitative PCR
30%
CRLF2
30%
Multiplex
23%
NanoString
23%
Fluorescence in Situ Hybridization
23%
NCounter
23%
Flow Cytometry
15%
Treatment Outcome
15%
Low-middle Income Countries
15%
Disease Assay
15%
Genetic Modification
7%
Clinically Significant
7%
High Risk
7%
High Incidence
7%
Newly Diagnosed
7%
Cost-effective Approach
7%
Gene Expression Profiling
7%
Significant Genes
7%
Statistical Significance
7%
Low-middle Income
7%
Induction Therapy
7%
Genetic Abnormalities
7%
Plain Language Summary
7%
Philadelphia Chromosome
7%
Total Leukocyte Count
7%
Income Regions
7%
Overexpressed Genes
7%
ABL1
7%
BCR-ABL1
7%
Gene Abnormality
7%
MUC4
7%
Induction Failure
7%
Genetic Subtypes
7%
AFF-1
7%
ETV6-RUNX1
7%
P2RY8
7%
IGH Rearrangement
7%
Male Preponderance
7%
TCF3-PBX1
7%
NRXN3
7%
SPATS2L
7%
Philadelphia-like ALL
7%
CEACAM6
7%
Multiplex Panel
7%
Biochemistry, Genetics and Molecular Biology
CRLF2
100%
Fluorescence in Situ Hybridization
75%
Reverse Transcription Polymerase Chain Reaction
75%
Philadelphia Chromosome
50%
Kinase
50%
Phosphotransferase
50%
Flow Cytometry
50%
Gene Expression Profiling
25%
MUC4
25%
Genetics
25%
AFF1
25%
Genetic Risk
25%
PBX1
25%
Real-Time Polymerase Chain Reaction
25%
Leukocyte Count
25%
RUNX1
25%
ETV6
25%
TCF3
25%
CEACAM6
25%
Genomics
25%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Minimal Residual Disease
55%
Fluorescence in Situ Hybridization
33%
Reverse Transcription Polymerase Chain Reaction
33%
Flow Cytometry
22%
Phosphotransferase
22%
Philadelphia 1 Chromosome
22%
Health Care Cost
22%
Low and Middle Income Countries
22%
Leukocyte
11%
Gene Expression Profiling
11%
Genetic Risk
11%
Mucin 4
11%
Real-Time Polymerase Chain Reaction
11%
Carcinoembryonic Antigen Related Cell Adhesion Molecule 6
11%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Minimal Residual Disease
55%
RNA Directed DNA Polymerase
33%
Flow Cytometry
22%
Phosphotransferase
22%
Philadelphia 1 Chromosome
22%
Genetic Risk
11%
Mucin 4
11%
Carcinoembryonic Antigen Related Cell Adhesion Molecule 6
11%